Invited commentary  by Quinones-Baldrich, William J.
JOURNAL OF VASCULAR SURGERY
March 2005380 Abraham et alnique.2,5,8-10 The cost-effectiveness of endovascular AAA
repair needs further assessment.11-16
We conclude from this study that there is biochemical
evidence of previously underestimated myocardial damage
associated with elective AAA repair regardless of the type of
repair. This subclinical damage is probably significantly less
with endovascular than with open repair. This finding
should be taken into account when deciding on themethod
of AAA repair, even when the patient is considered to be
low risk.
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Troponin T is 1 of 3 polypeptide chains that make up the
troponin complex. It is a cardiac-specific protein that binds to
tropomyosin and is released only from injured heart cells. Cardiacdial damage. The cause of the damage can range from strenuous
exercise to myocardial ischemia. Other causes of increased tropo-
nin without myocardial infarction include congestive heart failure,
pericarditis, pulmonary embolism, myocarditis, and sepsis. In the
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Volume 41, Number 3 Abraham et al 381absence of other clinical or electrocardiographic evidence of myo-
cardial infarction, increased levels can be of prognostic value.
Cardiac troponin T increases after coronary artery bypass grafting
are associated with increased mortality at 1 year.1 Asymptomatic
troponin increases in patients after vascular surgery have been
associated with significantly higher mortality at a median follow-up
of 4 years.2
This report by Abraham et al documents postoperative asymp-
tomatic troponin T increases that are higher in patients undergo-
ing open abdominal aortic aneurysm repair compared with an
endovascular approach. This implies increased myocardial strain
during the open procedure. The difference between the 2 groups is
more significant given that the incidence of coronary artery disease
documented before surgery was higher in the endovascular group.
Besides myocardial ischemia, other explanations for this finding
include increased blood loss and hypotension during the open
procedure. In the absence of these complications, a postoperative
troponin T increase is even more significant because it implies
myocardial damage under less stress. It is important to note thattroponin T measurement can be less accurate than troponin I.
Although increases in troponin T in the absence of other indicators
of myocardial ischemia were not associated with an increase in
perioperative morbidity or mortality, they identify a group of
patients who remain at increased risk of myocardial events during
follow-up. These patients should undergo further evaluation to
exclude significant coronary artery disease. These findings con-
tinue to support the notion that endovascular abdominal aortic
aneurysm repair is to be preferred, particularly in higher-risk pa-
tients.
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